arrow
S

Sara Pini

university of modena and reggio-emilia
H指数:10
被引数:792

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabolomics Reveals Multiple Metabolic Alterations and Biomarkers of Disease Severity in Facioscapulohumeral Muscle Dystrophy

代谢组学揭示面肩肱型肌营养不良中多种代谢改变与疾病严重程度的生物标志物

2026-11-130
OAAI
The CoMPaSS ‐ NMD Atlas Platform: A Secure Multimodal Infrastructure for Harmonized Data Collection, Exploration, and Future Artificial Intelligence–Driven Stratification in Hereditary Neuromuscular Disorders

<scp>CoMPaSS</scp>‐<scp>NMD</scp> 地图平台:一种用于遗传性神经肌肉疾病的标准化数据收集、探索和未来人工智能驱动分层的安全多模态基础设施

2026-11-120
OAAI
The challenge of science for sustainable agriculture: an Italian early career researchers' perspective

可持续农业中的科学挑战:意大利早期职业研究者的视角

2025-12-010
PRE
Nucleolar FRG2 lncRNAs inhibit rRNA transcription and cytoplasmic translation, linking FSHD to dysregulation of muscle-specific protein synthesis

核仁FRG2 lncRNAs抑制rRNA转录和细胞质翻译,将FSHD与肌肉特异性蛋白质合成的失调联系起来

2025-07-221
OA
Clinical impact of relative dose intensity of cabozantinib during the first 8 weeks and of subsequent dose reductions in patients with unresectable hepatocellular carcinoma
2023-09-010
PRE
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma

卡博替尼治疗不可切除肝细胞癌的真实临床数据

2021-06-1532
OAAI
Real-life clinical data of cabozantinib for unresectable hepato-cellular carcinoma: efficacy, safety and prognostic factors
2021-03-010
PREAI
Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer

Fdg-pet/CT对局部进展期直肠癌新辅助放化疗和根治性手术患者预后预测价值的前瞻性研究

2011-03-0173
OAAI